A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Dina Abushanab, Daoud Al‐Badriyeh, Clara Marquina, Cate Bailey, Myriam Jaam, Danny Liew, Zanfina Ademi
Topics & Concepts
EzetimibeMedicineStatinFenofibrateType 2 Diabetes MellitusNiacinProprotein convertaseType 2 diabetesInternal medicinePharmacologyDiabetes mellitusMetforminCost effectivenessEndocrinologyCholesterolLipoproteinRisk analysis (engineering)LDL receptorLipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life